美国假体周围股骨骨折后的死亡率、感染率与骨不连率如何
结果显示骨折发生率显著上升,1年死亡率约21%–24%,5年死亡率约57%–63%,骨折相关感染2年内约5%–7%,骨不连或畸形愈合约1%–4%。
要点
- 2010至2019年假体周围股骨骨折发生率陡增(全膝关节置换术后远端骨折IRR 3.3,全髋关节置换术后近端骨折IRR 2.3)。
- 骨折后1年死亡率约21%–24%,5年死亡率约57%–63%。
- 2年内骨折相关感染约5%–7%,骨不连或畸形愈合约1%–4%。
核心结论
- 研究期间假体周围骨折数量增加。
- Medicare患者假体周围股骨骨折后1年和5年死亡率高。
- 脑血管病、慢性肾病、糖尿病、病态肥胖、骨质疏松和类风湿关节炎是死亡率增加的危险因素。
- 骨折相关感染和骨不连发生率较高,对患者构成严重风险。
- 作者认为可通过老年创伤学跨学科团队提升患者福祉并降低术后死亡风险。
研究设计与样本
- 回顾性、比较性、大型数据库研究。
- 骨折按全膝关节置换术后和全髋关节置换术后分为近端、远端和骨干骨折。
- 按年计算假体周围股骨骨折发生率,以2019年发生率除以2010年发生率计算发生率比(IRR)。
- 采用Kaplan-Meier法及Fine和Gray子分布适应计算死亡、感染和骨不连的累积发生率。
主要发现
- 2010至2019年假体周围股骨骨折发生率陡增:全膝关节置换术后远端骨折IRR 3.3(95% CI 1至9;p=0.02);全髋关节置换术后近端骨折IRR 2.3(95% CI 1至4;p=0.01)。
- 1年死亡率:全髋关节置换术后远端骨折23%(95% CI 18%至28%),全髋关节置换术后近端骨折21%(95% CI 19%至24%),全髋关节置换术后骨干骨折22%(95% CI 19%至26%),全膝关节置换术后远端骨折21%(95% CI 18%至25%),全膝关节置换术后近端骨折22%(95% CI 17%至28%),全膝关节置换术后骨干骨折24%(95% CI 19%至29%)。
- 5年死亡率:全髋关节置换术后远端骨折63%(95% CI 54%至70%),全髋关节置换术后近端骨折57%(95% CI 54%至62%),全髋关节置换术后骨干骨折58%(95% CI 52%至63%),全膝关节置换术后远端骨折57%(95% CI 52%至62%),全膝关节置换术后近端骨折57%(95% CI 49%至65%),全膝关节置换术后骨干骨折57%(95% CI 49%至64%)。
- 年龄大于75岁、男性、慢性阻塞性肺疾病(全髋关节置换术后HR 1.48 [95% CI 1.32至1.67],全膝关节置换术后HR 1.45 [95% CI 1.20至1.74])、全髋关节置换术后脑血管病、慢性肾病(全髋关节置换术后HR 1.28 [95% CI 1.12至1.46],全膝关节置换术后HR 1.50 [95% CI 1.24至1.82])、糖尿病、病态肥胖、骨质疏松和类风湿关节炎是死亡率增加的临床危险因素。
- 2年内骨折相关感染:全髋关节置换术后远端骨折5%(95% CI 4%至7%),全髋关节置换术后近端骨折5%(95% CI 5%至6%),全髋关节置换术后骨干骨折6%(95% CI 5%至7%),全膝关节置换术后远端骨折6%(95% CI 5%至7%),全膝关节置换术后近端骨折7%(95% CI 5%至9%),全膝关节置换术后骨干骨折6%(95% CI 4%至8%)。
临床怎么用
- 作者认为可通过老年创伤学跨学科团队提升患者福祉,并应改善以降低术后死亡风险。
- 作者认为确保严格执行预防骨折相关感染的手术措施很重要。
- 作者认为需要继续改进植入物和手术技术以避免感染和骨不连等常致命并发症,并应在进一步研究中解决。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periprosthetic femoral fractures are a serious complication that put a high burden on patients. However, comprehensive analyses of their incidence, mortality, and complication rates based on large-registry data are scarce. QUESTIONS/PURPOSES: In this large-database study, we asked: (1) What is the incidence of periprosthetic femoral fractures in patients 65 years and older in the United States? (2) What are the rates of mortality, infection, and nonunion, and what factors are associated with these outcomes? METHODS: In this retrospective, comparative, large-database study, periprosthetic femoral fractures occurring between January 1, 2010, and December 31, 2019, were identified from Medicare physician service records encompassing services rendered in medical offices, clinics, hospitals, emergency departments, skilled nursing facilities, and other healthcare institutions from approximately 2.5 million enrollees. These were grouped into proximal, distal, and shaft fractures after TKA and THA. We calculated the incidence of periprosthetic femur fractures by year. Incidence rate ratios (IRR) were calculated by dividing the incidence in 2019 by the incidence in 2010. The Kaplan-Meier method with Fine and Gray subdistribution adaptation was used to calculate the cumulative incidence rates of mortality, infection, and nonunion. Semiparametric Cox regression was applied with 23 measures as covariates to determine factors associated with these outcomes. RESULTS: From 2010 to 2019, the incidence of periprosthetic femoral fractures increased steeply (TKA for distal fractures: IRR 3.3 [95% CI 1 to 9]; p = 0.02; THA for proximal fractures: IRR 2.3 [95% CI 1 to 4]; p = 0.01). One-year mortality rates were 23% (95% CI 18% to 28%) for distal fractures treated with THA, 21% (95% CI 19% to 24%) for proximal fractures treated with THA, 22% (95% CI 19% to 26%) for shaft fractures treated with THA, 21% (95% CI 18% to 25%) for distal fractures treated with TKA , 22% (95% CI 17% to 28%) for proximal fractures treated with TKA, and 24% (95% CI 19% to 29%) for shaft fractures treated with TKA. The 5-year mortality rate was 63% (95% CI 54% to 70%) for distal fractures treated with THA, 57% (95% CI 54% to 62%) for proximal fractures treated with THA, 58% (95% CI 52% to 63%) for shaft fractures treated with THA, 57% (95% CI 52% to 62%) for distal fractures treated with TKA , 57% (95% CI 49% to 65%) for proximal fractures treated with TKA, and 57% (95% CI 49% to 64%) for shaft fractures treated with TKA. Age older than 75 years, male sex, chronic obstructive pulmonary disease (HR 1.48 [95% CI 1.32 to 1.67] after THA and HR 1.45 [95% CI 1.20 to 1.74] after TKA), cerebrovascular disease after THA, chronic kidney disease (HR 1.28 [95% CI 1.12 to 1.46] after THA and HR 1.50 [95% CI 1.24 to 1.82] after TKA), diabetes mellitus, morbid obesity, osteoporosis, and rheumatoid arthritis were clinical risk factors for an increased risk of mortality. Within the first 2 years, fracture-related infections occurred in 5% (95% CI 4% to 7%) of patients who had distal fractures treated with THA, 5% [95% CI 5% to 6%]) of patients who had proximal fractures treated with THA, 6% (95% CI 5% to 7%) of patients who had shaft fractures treated with THA, 6% (95% CI 5% to 7%) of patients who had distal fractures treated with TKA , 7% (95% CI 5% to 9%) of patients who had proximal fractures treated with TKA, and 6% (95% CI 4% to 8%) of patients who had shaft fractures treated with TKA. Nonunion or malunion occurred in 3% (95% CI 2% to 4%) of patients with distal fractures treated with THA, 1% (95% CI 1% to 2%) of patients who had proximal fractures treated with THA, 2% (95% CI 1% to 3%) of patients who had shaft fractures treated with THA, 4% (95% CI 3% to 5%) of those who had distal fractures treated with TKA, , 2% (95% CI 1% to 4%) of those who had proximal fractures treated with TKA, and 3% (95% CI 2% to 4%) of those who had shaft fractures treated with TKA. CONCLUSION: An increasing number of periprosthetic fractures were observed during the investigated period. At 1 and 5 years after periprosthetic femur fracture, there was a substantial death rate in patients with Medicare. Conditions including cerebrovascular illness, chronic kidney disease, diabetes mellitus, morbid obesity, osteoporosis, and rheumatoid arthritis are among the risk factors for increased mortality. After the surgical care of periprosthetic femur fractures, the rates of fracture-related infection and nonunion were high, resulting in a serious risk to affected patients. Patient well-being can be enhanced by an interdisciplinary team in geriatric traumatology and should be improved to lower the risk of postoperative death. Additionally, it is important to ensure that surgical measures to prevent fracture-related infections are followed diligently. Furthermore, there is a need to continue improving implants and surgical techniques to avoid often-fatal complications such as fracture-associated infections and nonunion, which should be addressed in further studies. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Walter N, Szymski D, Kurtz SM, et al. What Are the Mortality, Infection, and Nonunion Rates After Periprosthetic Femoral Fractures in the United States? Clin Orthop Relat Res. 2023. PMID: 37678213. doi:10.1097/CORR.0000000000002825
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。